Marie-France Marin

Behavioral Neuroscience · 2011

A researcher in the Science corpus: 1 paper; trusts 4 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Marie-France Marin trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Bruce S. McEwen
  2. R. Sapolsky
  3. Michael Joseph Meaney
  4. Dennis S. Charney
  5. Y. Chida
  6. E. Kajantie
  7. P. Gold
  8. George P. Chrousos
  9. Andrew Steptoe
  10. D. Phillips

Who trusts Marie-France Marin overall

  1. Barbara J Lehman

Papers from Marie-France Marin's perspective

Ordered by how strongly the researchers Marie-France Marin trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress. (American Journal of Psychiatry)
  2. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states (Molecular Psychiatry)
  3. Limbic system mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis. (Progress in Neuro-psychopharmacology and Biological Psychiatry)
  4. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. (Archives of General Psychiatry)
  5. Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. (Annual Review of Neuroscience)
  6. The neurobiology of stress: from serendipity to clinical relevance. (Brain Research)
  7. Violence and risk of PTSD, major depression, substance abuse/dependence, and comorbidity: results from the National Survey of Adolescents. (Journal of Consulting and Clinical Psychology)
  8. The effects of sex and hormonal status on the physiological response to acute psychosocial stress. (Psychoneuroendocrinology)
  9. Cortisol awakening response and psychosocial factors: a systematic review and meta-analysis. (Biological Psychology)
  10. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. (Archives of Neurology)

Their papers